Changes in extracellular matrix in failing human non-ischemic and ischemic hearts with mechanical unloading

Yimu Zhao1, Amandine Godier-Furnemont1, Noortje A M Bax2

  • 1Department of Biomedical Engineering, Columbia University, New York 10032, USA.

Insights

This study reveals how the extracellular matrix (ECM) in ischemic and non-ischemic cardiomyopathies affects heart cell function. Understanding these differences is key for developing targeted therapies for heart failure.

Area of Science:

  • Cardiovascular Biology
  • Biomaterials Science
  • Translational Medicine

Background:

  • Distinct etiologies of ischemic and non-ischemic cardiomyopathies necessitate targeted therapeutic strategies.
  • The extracellular matrix (ECM) plays a critical role in cardiac function and disease.
  • Understanding the interplay between ECM and cardiomyocytes is crucial for heart failure treatment.

Purpose of the Study:

  • To characterize extracellular matrix (ECM) changes in ischemic and non-ischemic cardiomyopathies.
  • To investigate the influence of diseased human ECM on cardiomyocyte function using tissue engineering.
  • To explore the differential disease phenotypes and reverse remodeling potential of mechanical unloading, such as left ventricular assist device (LVAD) support.

Main Methods:

  • Analysis of human myocardium from healthy, ischemic, and non-ischemic heart failure patients.
  • Application of tissue engineering methodologies to assess ECM-cardiomyocyte interactions.
  • Transcriptomic, proteomic, and structural analyses of heart tissues.
  • Evaluation of left ventricular assist device (LVAD) support effects.

Main Results:

  • Differential ECM compositions were identified in ischemic and non-ischemic failing hearts.
  • Diseased human ECM recapitulated disease microenvironments and induced cardiomyocyte dysfunction.
  • Molecular profiles distinguishing non-ischemic and ischemic heart failure were revealed.
  • Etiology-specific impacts on LVAD support outcomes and reverse remodeling were explored.

Conclusions:

  • Extracellular matrix (ECM) alterations are central to the distinct pathobiology of ischemic and non-ischemic cardiomyopathies.
  • Diseased ECM significantly influences cardiomyocyte function, independent of systemic factors.
  • Findings provide insights into etiology-specific responses to mechanical unloading and potential for reverse remodeling.

Related Concept Videos

Extracellular Matrix01:26

Extracellular Matrix

Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
3.8K
Cell-matrix's Response to Mechanical Forces01:13

Cell-matrix's Response to Mechanical Forces

In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. 
Anchoring junctions mechanically attach a cell to the...
2.8K
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
9.6K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
87